LS

Lucia Seminario‐Vidal

Eli Lilly (United States) US

ORCID 0000-0002-6004-2451
190
Publications
2,435
Citations
26
H-Index
47
i10-Index
2.43
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

Cutaneous lymphoproliferative disorders research (86) Lymphoma Diagnosis and Treatment (59) CAR-T cell therapy research (55) Drug-Induced Adverse Reactions (24) Autoimmune Bullous Skin Diseases (21)

Affiliations

Northwestern University
US 2023 - 2023
University of North Carolina at Chapel Hill
US 2020 - 2008
University of Connecticut
US 2023 - 2023
Medical University of South Carolina
US 2023 - 2022
Eli Lilly (United States)
US 2025 - 2023

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now